Spots Global Cancer Trial Database for cisplatin or carboplatin
Every month we try and update this database with for cisplatin or carboplatin cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| A Phase 1b/2 Study of OMP-59R5 (Tarextumab) in Combination With Etoposide and Platinum Therapy | NCT01859741 | Stage IV Small ... | OMP-59R5 Etoposide Placebo Cisplatin or Ca... | 18 Years - 90 Years | Mereo BioPharma | |
| A Study of Carilizumab Combined With Concurrent Chemoradiotherapy | NCT05151549 | Cervical Cancer | Camrelizumab Cisplatin or Ca... | 18 Years - | Hunan Cancer Hospital | |
| Lorlatinib in Combination With Chemotherapy in Participants With Metastatic Anaplastic Lymphoma Kinase Positive (ALK+) Non-small Cell Lung Cancer (NSCLC) Who Progressed on Single-agent Lorlatinib | NCT05948462 | Lung Cancer Non-small Cell ... | Lorlatinib Cisplatin or Ca... Pemetrexed | 18 Years - | SCRI Development Innovations, LLC | |
| Safety and Efficacy of TTFields (150 kHz) Concomitant With Pemetrexed and Cisplatin or Carboplatin in Malignant Pleural Mesothelioma (STELLAR) | NCT02397928 | Malignant Pleur... | NovoTTF-100L de... Pemetrexed Cisplatin or Ca... | 18 Years - | NovoCure Ltd. | |
| ERBITUX® Followed by Adjuvant Treatment With Chemoradiation and ERBITUX® for Locally Advanced Head and Neck Squamous Cell Carcinoma | NCT01218048 | Squamous Cell C... | Cetuximab Surgery Post-surgical r... Cisplatin or ca... | 18 Years - | University of Pittsburgh | |
| A Study of Nivolumab and Chemotherapy Followed by Surgery for Mesothelioma | NCT04162015 | Malignant Pleur... | Nivolumab Pemetrexed Cisplatin or Ca... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| A Phase 1b/2 Study of OMP-59R5 (Tarextumab) in Combination With Etoposide and Platinum Therapy | NCT01859741 | Stage IV Small ... | OMP-59R5 Etoposide Placebo Cisplatin or Ca... | 18 Years - 90 Years | Mereo BioPharma | |
| Safety and Efficacy of TTFields (150 kHz) Concomitant With Pemetrexed and Cisplatin or Carboplatin in Malignant Pleural Mesothelioma (STELLAR) | NCT02397928 | Malignant Pleur... | NovoTTF-100L de... Pemetrexed Cisplatin or Ca... | 18 Years - | NovoCure Ltd. | |
| Study of Gefitinib Compared With Pemetrexed/Cisplatin in Advanced Non-Small Cell Lung Cancer Patients | NCT01192243 | Toxicity Non-small Cell ... | Gefitinib Pemetrexed Cisplatin or ca... | 18 Years - 70 Years | Fudan University | |
| A Study of Nivolumab and Chemotherapy Followed by Surgery for Mesothelioma | NCT04162015 | Malignant Pleur... | Nivolumab Pemetrexed Cisplatin or Ca... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Study of Gefitinib Compared With Pemetrexed/Cisplatin in Advanced Non-Small Cell Lung Cancer Patients | NCT01192243 | Toxicity Non-small Cell ... | Gefitinib Pemetrexed Cisplatin or ca... | 18 Years - 70 Years | Fudan University | |
| ERBITUX® Followed by Adjuvant Treatment With Chemoradiation and ERBITUX® for Locally Advanced Head and Neck Squamous Cell Carcinoma | NCT01218048 | Squamous Cell C... | Cetuximab Surgery Post-surgical r... Cisplatin or ca... | 18 Years - | University of Pittsburgh | |
| A Study of Carilizumab Combined With Concurrent Chemoradiotherapy | NCT05151549 | Cervical Cancer | Camrelizumab Cisplatin or Ca... | 18 Years - | Hunan Cancer Hospital | |
| Adebrelimab Plus Chemotherapy as Neoadjuvant Therapy in Resectable NSCLC Harboring Driver Gene Mutations | NCT06299371 | Non Small Cell ... | Adebrelimab paclitaxel for ... Cisplatin or Ca... | 18 Years - | Liaoning Tumor Hospital & Institute | |
| A Study of AK104（ an Anti-PD-1 and Anti-CTLA-4 Bispecific Antibody) in Recurrent or Metastatic Cervical Cancer | NCT04868708 | Recurrent or Me... | AK104 Bevacizumab Paclitaxel Cisplatin or Ca... | 18 Years - 75 Years | Akeso | |
| Lorlatinib in Combination With Chemotherapy in Participants With Metastatic Anaplastic Lymphoma Kinase Positive (ALK+) Non-small Cell Lung Cancer (NSCLC) Who Progressed on Single-agent Lorlatinib | NCT05948462 | Lung Cancer Non-small Cell ... | Lorlatinib Cisplatin or Ca... Pemetrexed | 18 Years - | SCRI Development Innovations, LLC | |
| A Study of Camrelizumab Combined With Concurrent Chemoradiation in Patients With Cervical Cancer | NCT04974827 | Cervical Cancer | Camrelizumab Cisplatin or Ca... | 18 Years - | Hunan Cancer Hospital |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
